Ziel
HeCaToS aims at developing integrative in silico tools for predicting human liver and heart toxicity. The objective is to develop an integrated modeling framework, by combining advances in computational chemistry and systems toxicology, for modelling toxic perturbations in liver and heart across multiple scales. This framework will include vertical integrations of representations from drug(metabolite)-target interactions, through macromolecules/proteins, to (sub-)cellular functionalities and organ physiologies, and even the human whole-body level. In view of the importance of mitochondrial deregulations and of immunological dysfunctions associated with hepatic and cardiac drug-induced injuries, focus will be on these particular Adverse Outcome Pathways. Models will be populated with data from innovative in vitro 3D liver and heart assays challenged with prototypical hepato- or cardiotoxicants; data will be generated by advanced molecular and functional analytical techniques retrieving information on key (sub-)cellular toxic evens. For validating perturbed AOPs in vitro in appropriate human investigations, case studies on patients with liver injuries or cardiomyopathies due to adverse drug effects, will be developed, and biopsies will be subjected to similar analyses. Existing ChEMBL and diXa data infrastructures will be advanced for data gathering, storing and integrated statistical analysis. Model performance in toxicity prediction will be assessed by comparing in silico predictions with experimental results across a multitude of read-out parameters, which in turn will suggest additional experiments for further validating predictions. HeCaToS, organized as a private-public partnership, will generate major socioeconomic impact because it will develop better chemical safety tests leading to safer drugs, but also industrial chemicals, and cosmetics, thereby improving patient and consumer health, and sustaining EU’s industrial competitiveness.
Wissenschaftliches Gebiet
Programm/Programme
Thema/Themen
Aufforderung zur Vorschlagseinreichung
FP7-HEALTH-2013-INNOVATION-1
Andere Projekte für diesen Aufruf anzeigen
Finanzierungsplan
CP-IP - Large-scale integrating projectKoordinator
6200 MD Maastricht
Niederlande
Auf der Karte ansehen
Beteiligte (13)
4070 Basel
Auf der Karte ansehen
8952 Schlieren
Auf der Karte ansehen
46026 Valencia
Auf der Karte ansehen
8092 Zuerich
Auf der Karte ansehen
SW7 2AZ LONDON
Auf der Karte ansehen
T12 Cork
Auf der Karte ansehen
69117 Heidelberg
Auf der Karte ansehen
4053 BASEL
Auf der Karte ansehen
80539 Munchen
Auf der Karte ansehen
WC2R 2LS London
Auf der Karte ansehen
52062 Aachen
Auf der Karte ansehen
10405 Berlin
Auf der Karte ansehen
CB25 9PB Cambridge
Auf der Karte ansehen